$CNAT : From StockNews.com https://stocknews.com/news/cnat-granted-orphan-designation-by-the-fda-for-its-compound-for/ CNAT – Granted orphan designation by the FDA for its compound for the treatment of primary sclerosing cholangitis. Full disclosure, I can't find it on the FDA website (yet anyway) or the company's website. ???